Recent Transactions

18-Aug-16
$3.2 billion
Switzerland flag
Target: 

Valves & Controls Business of Pentair

United States flag
Acquiror: 
Emerson

Advised Emerson, a diversified global technology and industrial company, on the acquisition of the Valves & Controls business of Pentair

08-Aug-16
$1.5 billion
Canada flag
Target: 

Whistler Blackcomb Holdings Inc.

United States flag
Acquiror: 
Vail Resorts, Inc.

Advised Whistler Blackcomb Holdings Inc., a 75% owner and operator of the largest and most visited mountain resort in North America, on its sale to Vail Resorts, Inc.

08-Aug-16
$87 million
United States flag
Target: 

Aquasana, Inc.

United States flag
Acquiror: 
A. O. Smith Corporation

Advised A. O. Smith Corporation, a leading manufacturer of residential and commercial water heaters and boilers, on the acquisition of Aquasana, a premium water treatment company, from L Catterton

28-Jul-16
$80 million
United States flag
Target: 

BioD, LLC

United States flag
Acquiror: 
Derma Sciences, Inc.

Advised Derma Sciences, Inc., a tissue regeneration company focused on advanced wound and burn care, on the acquisition of a proprietary regenerative medicine products company BioD, LLC and a concurrent private placement.

28-Jun-16
$NA
Israel flag
Target: 

U.S. rights to an authorized generic version of Adderall XR

United States flag
Acquiror: 
Prasco Laboratories

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the U.S. rights  to an authorized generic version of Adderall XR

28-Jun-16
$652 million
Israel flag
Target: 

U.S. rights to 37 approved and 5 pipeline generic products

Australia flag
Acquiror: 
Mayne Pharma Group Limited

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the U.S. rights  to 42 generic products

27-Jun-16
$156 million
United States flag
Target: 

ReachLocal

United States flag
Acquiror: 
Gannett

Served as independent financial advisor to the Board of Directors of Gannett in connection with its acquisition of ReachLocal

21-Jun-16
$586 million
Israel flag
Target: 

U.S. rights to a broad portfolio of 18 generic products from Teva Pharmaceutical Industries Ltd.

United States flag
Acquiror: 
Impax Laboratories, Inc.

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the U.S. rights to a broad portfolio of 18 generic products to Impax Laboratories, Inc.

20-Jun-16
$NA
Israel flag
Target: 

U.S. rights to 2 generic drug products from Teva Pharmaceutical Industries Ltd.

India flag
Acquiror: 
Zydus Cadila

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the U.S. rights to 2 generic drug products to Zydus Cadila

16-Jun-16
$40 million
Israel flag
Target: 

U.S. rights to 5 generic injectable drug products from Teva Pharmaceutical Industries Ltd.

United States flag
Acquiror: 
Sagent Pharmaceuticals, Inc.

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the U.S. rights to 5 generic injectable drug products  to Sagent Pharmaceuticals, Inc. 

15-Jun-16
$414 million
United States flag
Target: 

Aegerion Pharmaceuticals

Canada flag
Acquiror: 
QLT Inc.

Advised QLT Inc. on its merger with Aegerion Pharmaceuticals and concurrent equity raise to create a rare disease-focused global biopharmaceutical organization

11-Jun-16
$350 million
Israel flag
Target: 

U.S. rights to 8 generic drug products from Teva Pharmaceutical Industries Ltd.

India flag
Acquiror: 
Dr. Reddy’s Laboratories

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the U.S. rights to 8 generic drug products to Dr. Reddy’s Laboratories

16-May-16
$874 million
U.K., Netherlands, Germany flags
Target: 

Equinix Data Center Assets

United States flag
Acquiror: 
Digital Realty Trust

Advised Digital Realty Trust, the world's largest wholesale colocation services and data center solutions provider, on its acquisition of a portfolio of eight carrier-neutral European data centers from Equinix

04-May-16
$NA
United States flag
Target: 

Portfolio of synthetic royalty and milestone rights on multiple cardiovascular programs

United States flag
Acquiror: 
Ligand Pharmaceuticals

Advised CorMatrix Cardiovascular, a leading medical device company with a differentiated extracellular matrix technology, on the sale of a portfolio of synthetic royalty and milestone rights on multiple cardiovascular programs

04-May-16
$NA
United States flag
Target: 

Affinia Group

Germany flag
Acquiror: 
MANN+HUMMEL GmbH

Advised MANN+HUMMEL GmbH, a leading global manufacturer of filtration solutions, on the acquisition of the global filtration operations (excluding the Affinia South America operations) of Affinia Group

28-Apr-16
$550 million
United States flag
Target: 

Broadcom’s Wireless Internet of Things (IoT) Business Unit

United States flag
Acquiror: 
Cypress Semiconductor Corporation

Advised Cypress Semiconductor, a leading provider of high-performance, mixed-signal, programmable solutions worldwide, on its acquisition of Broadcom’s Wi-Fi, Bluetooth and ZigBee product lines for automotive, industrial and consumer IoT markets

25-Apr-16
$3.4 billion
U.S.A., Euro, Brazil flags
Target: 

Divestment assets of Ball and Rexam

Luxembourg flag
Acquiror: 
Ardagh Group SA

Advised Ball Corporation on the acquisition of Rexam plc and provided a fairness opinion to the Board of Directors of Ball Corporation on the sale of select metal beverage can assets in Europe, Brazil and the United States to satisfy certain regulatory requirements in connection with its proposed acquisition of Rexam

22-Apr-16
$NA
Brazil flag
Target: 

Elavon do Brasil

Brazil flag
Acquiror: 
Stone Pagamentos

Advised Minneapolis-based U.S. Bancorp, the fifth largest commercial bank in the United States, and the parent company of Elavon, Inc., in the sale of its 50.1 percent majority stake in São Paulo-based, Elavon do Brasil to Stone Pagamentos, a local market, privately-held merchant acquirer.

19-Apr-16
$NA
United States flag
Target: 

Total Care Medicaid Plan

United States flag
Acquiror: 
Molina Healthcare, Inc.

Advised Molina Healthcare Inc., a provider of managed health care services under the Medicaid and Medicare programs, on the acquisition of Universal American’s Total Care Medicaid plan

14-Apr-16
$NA
United Kingdom flag
Target: 

Frieze Events Ltd. / Frieze Publishing Ltd.

United States flag
Acquiror: 
WME | IMG Global

Advised Frieze, the premier art events and media company, on its strategic investment and partnership with WME IMG Global

18-Mar-16
$NA
China flag
Target: 

Sewells Group

United States flag
Acquiror: 
MSX International

Advised WorldMark on the sale of Sewells Group to MSX International, a global provider of outsourced business solutions.  Sewells, headquartered in Shanghai, is a leading provider of automotive dealership development services across Asia Pacific, Africa and the Middle East

16-Mar-16
$942 million
United States flag
Target: 

Rofin-Sinar Technologies, Inc.

United States flag
Acquiror: 
Coherent, Inc.

Advised Rofin-Sinar Technologies, Inc., a leading manufacturer of industrial laser sources and laser-based solutions and components, on its sale to Coherent, Inc., a leading provider of lasers and laser-based technology for scientific, commercial and industrial customers

07-Mar-16
$NA
Germany flag
Target: 

Boehringer Ingelheim

United States flag
Acquiror: 
AbbVie

Advised Boehringer Ingelheim, the world's largest privately held pharmaceutical company, on a global collaboration with AbbVie regarding an investigational monoclonal IL-23 antibody targeting autoimmune diseases. Within the scope of the agreement, AbbVie also acquired an option for the development and commercialisation of BI’s anti-CD-40 antibody.

03-Mar-16
$NA
United States flag
Target: 

Perseus Books LLC

United States flag
Acquiror: 
Ingram Content Group Inc.

Advised Perseus Books LLC, a leading independent publishing company, on the sale of its client services business to Ingram Content Group Inc. 

01-Mar-16
$NA
United States flag
Target: 

Perseus Books LLC

United States flag
Acquiror: 
Hachette Book Group, Inc.

Advised Perseus Books LLC, a leading independent publishing company, on the sale of its publishing business to Hachette Book Group, Inc. 

Pages

show all